This is a Validated Antibody Database (VAD) review about human SRSF1, based on 50 published articles (read how Labome selects the articles), using SRSF1 antibody in all methods. It is aimed to help Labome visitors find the most suited SRSF1 antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
SRSF1 synonym: ASF; SF2; SF2p33; SFRS1; SRp30a

Invitrogen
mouse monoclonal (96)
  • western blot; human; 1:2000; loading ...; fig 3d
Invitrogen SRSF1 antibody (Thermo Fisher, 32-4500) was used in western blot on human samples at 1:2000 (fig 3d). Nat Commun (2019) ncbi
mouse monoclonal (96)
  • other; human; loading ...; fig 4c
Invitrogen SRSF1 antibody (Thermo Fisher Scientific, 32-4500) was used in other on human samples (fig 4c). Cancer Cell (2018) ncbi
mouse monoclonal (96)
  • reverse phase protein lysate microarray; human; loading ...; fig 7a
In order to characterize the molecular identity of uterine carcinosarcomas., Invitrogen SRSF1 antibody (Invitrogen, 32-4500) was used in reverse phase protein lysate microarray on human samples (fig 7a). Cancer Cell (2017) ncbi
mouse monoclonal (96)
  • reverse phase protein lysate microarray; human; loading ...; fig 3a
In order to describe the features of 228 primary cervical cancers, Invitrogen SRSF1 antibody (Invitrogen, 32-4500) was used in reverse phase protein lysate microarray on human samples (fig 3a). Nature (2017) ncbi
mouse monoclonal (96)
  • western blot; human; loading ...; fig 6a
In order to study cryptic 5'ss splice donor recognition and selection within the human fibrinogen Bbeta-chain gene exon 7, Invitrogen SRSF1 antibody (Invitrogen, 32-4500) was used in western blot on human samples (fig 6a). Nucleic Acids Res (2017) ncbi
mouse monoclonal (103)
  • western blot; human; 1:100; loading ...; fig s1c
In order to clarify the regulatory role of Sat3 transcripts in heat-shock-dependent transcriptional repression, Invitrogen SRSF1 antibody (Invitrogen, 32-4600) was used in western blot on human samples at 1:100 (fig s1c). J Cell Sci (2016) ncbi
mouse monoclonal (96)
  • western blot; human; loading ...; fig 9b
In order to investigate alternative RNA splicing of HPV18 pre-mRNAs, Invitrogen SRSF1 antibody (Life Technologies, 96) was used in western blot on human samples (fig 9b). J Virol (2016) ncbi
mouse monoclonal (96)
  • western blot; mouse; fig 7
In order to characterize the involvement of concerted non-productive splicing of post-transcriptional regulators that involves the alternative splicing program of differentiatied smooth muscle cells, Invitrogen SRSF1 antibody (Invitrogen, 32-4500) was used in western blot on mouse samples (fig 7). Nucleic Acids Res (2016) ncbi
mouse monoclonal (103)
  • immunohistochemistry - paraffin section; human; 1:1000; fig 1
  • western blot; human; 1:1000; fig 1
In order to compare colorectal and gastric cancer and their expression patterns and diagnostic efficacies of SR splicing factors and HNRNPA1, Invitrogen SRSF1 antibody (Invitrogen, 324600) was used in immunohistochemistry - paraffin section on human samples at 1:1000 (fig 1) and in western blot on human samples at 1:1000 (fig 1). BMC Cancer (2016) ncbi
mouse monoclonal (96)
  • western blot; rat; 1:1000; tbl 1
In order to research pharmacologic modulation of GH-1 splicing due to rescue of isolated growth hormone deficiency type II (IGHD II), Invitrogen SRSF1 antibody (Invitrogen, 32-4500) was used in western blot on rat samples at 1:1000 (tbl 1). Endocrinology (2016) ncbi
mouse monoclonal (96)
  • western blot; human; 1:1000; fig 2
In order to assess regulation of SRSF3 (SRp20) to promote capsid protein expression in infected differentiated keratinocytes by human papillomavirus E2, Invitrogen SRSF1 antibody (Invitrogen, 32-4500) was used in western blot on human samples at 1:1000 (fig 2). J Virol (2016) ncbi
mouse monoclonal (96)
  • immunohistochemistry; human; fig s5
  • western blot; human; fig 7
  • western blot; mouse; fig 7
In order to characterize human osteosarcoma U2OS cells for genome landscape of SRSF3-regulated splicing events and gene expression, Invitrogen SRSF1 antibody (Invitrogen, 96) was used in immunohistochemistry on human samples (fig s5), in western blot on human samples (fig 7) and in western blot on mouse samples (fig 7). Nucleic Acids Res (2016) ncbi
mouse monoclonal (103)
  • immunohistochemistry; human; fig 1
In order to investigate how the 4.5SH cluster regulates SINE B1, Invitrogen SRSF1 antibody (Invitrogen, 32-4600) was used in immunohistochemistry on human samples (fig 1). Genes Cells (2015) ncbi
mouse monoclonal (96)
  • western blot; human
In order to characterize acetylcholinesterase mutations, Invitrogen SRSF1 antibody (Invitrogen, 32-4500) was used in western blot on human samples . Sci Rep (2015) ncbi
mouse monoclonal (96)
  • western blot; human
In order to investigate the therapeutic potential of splicinge-shifting oligonucleotide in the cblE type of homocystinuria, Invitrogen SRSF1 antibody (Zymed Laboratories, AK96) was used in western blot on human samples . Nucleic Acids Res (2015) ncbi
mouse monoclonal (103)
  • western blot; human; loading ...; fig 5i
In order to study the splicing regulation of the MDM2 oncogene., Invitrogen SRSF1 antibody (Novex, Life Technologies, 32-46000) was used in western blot on human samples (fig 5i). Nucleic Acids Res (2015) ncbi
mouse monoclonal (96)
  • western blot; human; 1:1000
In order to study the regulation of the human papillomavirus 16 oncoprotein expression, Invitrogen SRSF1 antibody (Zymed, 96) was used in western blot on human samples at 1:1000. J Virol (2015) ncbi
mouse monoclonal (96)
  • immunoprecipitation; human
In order to study the function of histone methyltransferase EHMT2 in VEGFA alternative splicing, Invitrogen SRSF1 antibody (Invitrogen, 32-4500) was used in immunoprecipitation on human samples . Nucleic Acids Res (2014) ncbi
mouse monoclonal (96)
  • chromatin immunoprecipitation; human
In order to investigate the function of the alanine repeat-containing C-terminal domain of RNA-binding motif protein 4, Invitrogen SRSF1 antibody (Invitrogen, 96) was used in chromatin immunoprecipitation on human samples . Nucleic Acids Res (2014) ncbi
mouse monoclonal (96)
  • western blot; human; fig 4
In order to study Kaposi sarcoma-associated herpesvirus ORF57 protein attenuates the suppressive activity of cellular splicing factor SRSF3 and is required by RNA splicing, Invitrogen SRSF1 antibody (Zymed, 32-4500) was used in western blot on human samples (fig 4). RNA (2014) ncbi
mouse monoclonal (103)
  • immunocytochemistry; human
In order to investigate the interaction of adipogenic transcriptional cofactor ZNF638 with splicing regulators and its effect on alternative splicing, Invitrogen SRSF1 antibody (Invitrogen, 32-4600) was used in immunocytochemistry on human samples . J Lipid Res (2014) ncbi
mouse monoclonal (103)
  • western blot; human
In order to investigate the role of FUBP1 in the splicing of oncogene MDM2 pre-mRNA, Invitrogen SRSF1 antibody (Invitrogen, 32-4600) was used in western blot on human samples . J Biol Chem (2014) ncbi
mouse monoclonal (103)
  • immunocytochemistry; human
  • western blot; human
In order to investigate the role of nuclear ARVCF protein during alternative splicing, Invitrogen SRSF1 antibody (Invitrogen, 32-4600) was used in immunocytochemistry on human samples and in western blot on human samples . J Biol Chem (2014) ncbi
mouse monoclonal (103)
  • immunocytochemistry; human; fig s8
In order to characterize mammalian nuclear RNA N6-adenosine methylation mediation by a METTL3-METTL14 complex, Invitrogen SRSF1 antibody (Invitrogen, 32-4600) was used in immunocytochemistry on human samples (fig s8). Nat Chem Biol (2014) ncbi
mouse monoclonal (96)
  • immunoprecipitation; human; fig 8
  • western blot; human; fig 8
In order to identify the adenovirus E4orf4 protein binding site on the B55alpha and Cdc55 regulatory subunits of P22A and its tumor cell killing and viral replication function, Invitrogen SRSF1 antibody (Zymed, 32-4500) was used in immunoprecipitation on human samples (fig 8) and in western blot on human samples (fig 8). PLoS Pathog (2013) ncbi
mouse monoclonal (96)
  • western blot; human
In order to investigate the HPV-16 splicing and its effect on primary human keratinocytes, Invitrogen SRSF1 antibody (Invitrogen, 96) was used in western blot on human samples . PLoS ONE (2013) ncbi
mouse monoclonal (96)
  • western blot; human; fig 3
In order to study a single-nucleotide polymorphism, rs211718C to T, located far upstream of the MCAD gene, Invitrogen SRSF1 antibody (Invitrogen, 32-4500) was used in western blot on human samples (fig 3). Mol Genet Metab (2013) ncbi
mouse monoclonal (96)
  • western blot; human; fig 1
In order to explore the mechanism underlying paraquat-induced pre-mRNA splicing alterations, Invitrogen SRSF1 antibody (Invitrogen, clone 96) was used in western blot on human samples (fig 1). PLoS ONE (2013) ncbi
mouse monoclonal (103)
  • immunocytochemistry; human
In order to study the mechanism for RNA splicing and termination factor recruitment to RNA polymerase II in vivo, Invitrogen SRSF1 antibody (Invitrogen, 32-4600) was used in immunocytochemistry on human samples . Nucleic Acids Res (2013) ncbi
mouse monoclonal (96)
  • immunohistochemistry - paraffin section; human; 1:1000
In order to study SRSF1 and SRSF2 in lung cancer, Invitrogen SRSF1 antibody (Invitrogen, 32-4500) was used in immunohistochemistry - paraffin section on human samples at 1:1000. PLoS ONE (2012) ncbi
mouse monoclonal (96)
  • western blot; human; fig 4
In order to assess the effect of the Glrb(spa) LINE1 insertion on pre-mRNA splicing, Invitrogen SRSF1 antibody (Invitrogen, 32-4500) was used in western blot on human samples (fig 4). J Biol Chem (2012) ncbi
mouse monoclonal (103)
  • western blot; mouse
In order to characterize Malat1-knockout mice, Invitrogen SRSF1 antibody (Invitrogen, 32-4600) was used in western blot on mouse samples . RNA (2012) ncbi
mouse monoclonal (96)
  • chromatin immunoprecipitation; mouse; 4 ug; fig 3
  • western blot; mouse; 1:2000; fig 3
In order to elucidate the role of Psip1/p52 in splicing, Invitrogen SRSF1 antibody (Invitrogen, 32-4500) was used in chromatin immunoprecipitation on mouse samples at 4 ug (fig 3) and in western blot on mouse samples at 1:2000 (fig 3). PLoS Genet (2012) ncbi
mouse monoclonal (96)
  • western blot; human; fig 2
In order to report that resveratrol modulates alternative splicing in a target-specific manner, Invitrogen SRSF1 antibody (Invitrogen, 32-4500) was used in western blot on human samples (fig 2). PLoS ONE (2011) ncbi
mouse monoclonal (103)
  • immunocytochemistry; human; 1:500; fig s2
  • western blot; human; 1:500; fig 6
In order to use single-molecule imaging to characterize the cell-to-cell variability in mRNA isoform ratios for endogenous CAPRIN1 and MKNK2, Invitrogen SRSF1 antibody (Invitrogen, 32-4600) was used in immunocytochemistry on human samples at 1:500 (fig s2) and in western blot on human samples at 1:500 (fig 6). Mol Syst Biol (2011) ncbi
mouse monoclonal (96)
  • western blot; human; 1:500; fig 4
In order to discuss how alternative splicing contributes to clear cell renal cell carcinoma, Invitrogen SRSF1 antibody (Invitrogen, 32-4500) was used in western blot on human samples at 1:500 (fig 4). PLoS ONE (2010) ncbi
mouse monoclonal (96)
  • chromatin immunoprecipitation; human; fig 8
In order to investigate the mechanisms by which SF2/ASF contributes to oncogenesis, Invitrogen SRSF1 antibody (Invitrogen, 32-4500) was used in chromatin immunoprecipitation on human samples (fig 8). Cell Cycle (2009) ncbi
mouse monoclonal (103)
  • immunocytochemistry; mouse; fig 1
In order to study the nuclear localization of several genes, Invitrogen SRSF1 antibody (Zymed, 32-4600) was used in immunocytochemistry on mouse samples (fig 1). Chromosoma (2008) ncbi
mouse monoclonal (103)
  • immunocytochemistry; human; 1:30; fig 6
In order to elucidate the function of S1-1, Invitrogen SRSF1 antibody (Zymed, 32-4600) was used in immunocytochemistry on human samples at 1:30 (fig 6). Biol Cell (2008) ncbi
mouse monoclonal (96)
  • western blot; human; 1:250; fig 2
In order to study human cytomegalovirus UL37 isoforms, Invitrogen SRSF1 antibody (Zymed, 32-4500) was used in western blot on human samples at 1:250 (fig 2). J Gen Virol (2004) ncbi
Santa Cruz Biotechnology
mouse monoclonal (96)
  • RNA immunoprecipitation; human; loading ...; fig 7i
Santa Cruz Biotechnology SRSF1 antibody (Santa Cruz, sc-33652) was used in RNA immunoprecipitation on human samples (fig 7i). Commun Biol (2022) ncbi
mouse monoclonal (3G268)
  • western blot; human; 1:1000; fig 3f
Santa Cruz Biotechnology SRSF1 antibody (Santa Cruz, sc-73026) was used in western blot on human samples at 1:1000 (fig 3f). Cell Death Dis (2021) ncbi
mouse monoclonal (96)
  • immunocytochemistry; human; loading ...; fig 4a
  • western blot; human; loading ...; fig 4a
  • western blot; mouse; loading ...; fig 4e
Santa Cruz Biotechnology SRSF1 antibody (Santa Cruz, sc-33652) was used in immunocytochemistry on human samples (fig 4a), in western blot on human samples (fig 4a) and in western blot on mouse samples (fig 4e). Nucleic Acids Res (2021) ncbi
mouse monoclonal (96)
  • western blot; human; 1:1000; loading ...; fig 1d
Santa Cruz Biotechnology SRSF1 antibody (Santa Cruz Biotechnology, sc-33652) was used in western blot on human samples at 1:1000 (fig 1d). elife (2020) ncbi
mouse monoclonal (96)
  • immunocytochemistry; mouse; 1:500; loading ...; fig 2a
Santa Cruz Biotechnology SRSF1 antibody (Santa Cruz, 33652) was used in immunocytochemistry on mouse samples at 1:500 (fig 2a). Nature (2019) ncbi
mouse monoclonal (3G268)
  • western blot; human; loading ...; fig 4b
Santa Cruz Biotechnology SRSF1 antibody (Santa Cruz Biotechnology, 3G268) was used in western blot on human samples (fig 4b). Cell Death Dis (2019) ncbi
mouse monoclonal (96)
  • western blot; mouse; 1:500; loading ...; fig s8c
  • western blot; human; 1:500; loading ...; fig s8c
Santa Cruz Biotechnology SRSF1 antibody (Santa Cruz Biotechnology, sc-33652) was used in western blot on mouse samples at 1:500 (fig s8c) and in western blot on human samples at 1:500 (fig s8c). Nat Commun (2018) ncbi
mouse monoclonal (1H4)
  • western blot; human; 1:200; fig 1
In order to investigate the impact of serine-arginine rich splicing factor 2 mutations to myelodysplastic syndrome, Santa Cruz Biotechnology SRSF1 antibody (Santa Cruz, sc-13,509) was used in western blot on human samples at 1:200 (fig 1). BMC Mol Biol (2016) ncbi
mouse monoclonal (96)
  • western blot; human; 1:100
In order to study the localization of AID and it's associated proteins, Santa Cruz Biotechnology SRSF1 antibody (Santa Cruz, sc-33652) was used in western blot on human samples at 1:100. Exp Cell Res (2014) ncbi
Abcam
domestic rabbit monoclonal (EPR8239)
  • western blot; human; loading ...; fig 4c
Abcam SRSF1 antibody (Abcam, ab129108) was used in western blot on human samples (fig 4c). J Mol Biol (2018) ncbi
Articles Reviewed
  1. Turco C, Esposito G, Iaiza A, Goeman F, Benedetti A, Gallo E, et al. MALAT1-dependent hsa_circ_0076611 regulates translation rate in triple-negative breast cancer. Commun Biol. 2022;5:598 pubmed publisher
  2. Duan Y, Jia Y, Wang J, Liu T, Cheng Z, Sang M, et al. Long noncoding RNA DGCR5 involves in tumorigenesis of esophageal squamous cell carcinoma via SRSF1-mediated alternative splicing of Mcl-1. Cell Death Dis. 2021;12:587 pubmed publisher
  3. Kim C, Park S, Lee S, Kim Y, Jang S, Woo S, et al. NSrp70 is a lymphocyte-essential splicing factor that controls thymocyte development. Nucleic Acids Res. 2021;49:5760-5778 pubmed publisher
  4. Ilik I, Malszycki M, Lübke A, Schade C, Meierhofer D, Aktas T. SON and SRRM2 are essential for nuclear speckle formation. elife. 2020;9: pubmed publisher
  5. Guo Y, Manteiga J, Henninger J, Sabari B, Dall Agnese A, Hannett N, et al. Pol II phosphorylation regulates a switch between transcriptional and splicing condensates. Nature. 2019;572:543-548 pubmed publisher
  6. Sajini A, Choudhury N, Wagner R, Bornelöv S, Selmi T, Spanos C, et al. Loss of 5-methylcytosine alters the biogenesis of vault-derived small RNAs to coordinate epidermal differentiation. Nat Commun. 2019;10:2550 pubmed publisher
  7. Donadoni M, Cicalese S, Sarkar D, Chang S, Sariyer I. Alcohol exposure alters pre-mRNA splicing of antiapoptotic Mcl-1L isoform and induces apoptosis in neural progenitors and immature neurons. Cell Death Dis. 2019;10:447 pubmed publisher
  8. Neueder A, Dumas A, Benjamin A, Bates G. Regulatory mechanisms of incomplete huntingtin mRNA splicing. Nat Commun. 2018;9:3955 pubmed publisher
  9. Sithole N, Williams C, Vaughan A, Kenyon J, Lever A. DDX17 Specifically, and Independently of DDX5, Controls Use of the HIV A4/5 Splice Acceptor Cluster and Is Essential for Efficient Replication of HIV. J Mol Biol. 2018;430:3111-3128 pubmed publisher
  10. Ng P, Li J, Jeong K, Shao S, Chen H, Tsang Y, et al. Systematic Functional Annotation of Somatic Mutations in Cancer. Cancer Cell. 2018;33:450-462.e10 pubmed publisher
  11. Cherniack A, Shen H, Walter V, Stewart C, Murray B, Bowlby R, et al. Integrated Molecular Characterization of Uterine Carcinosarcoma. Cancer Cell. 2017;31:411-423 pubmed publisher
  12. . Integrated genomic and molecular characterization of cervical cancer. Nature. 2017;543:378-384 pubmed publisher
  13. Brillen A, Schöneweis K, Walotka L, Hartmann L, Muller L, Ptok J, et al. Succession of splicing regulatory elements determines cryptic 5΄ss functionality. Nucleic Acids Res. 2017;45:4202-4216 pubmed publisher
  14. Skrdlant L, Stark J, Lin R. Myelodysplasia-associated mutations in serine/arginine-rich splicing factor SRSF2 lead to alternative splicing of CDC25C. BMC Mol Biol. 2016;17:18 pubmed publisher
  15. Goenka A, Sengupta S, Pandey R, Parihar R, Mohanta G, Mukerji M, et al. Human satellite-III non-coding RNAs modulate heat-shock-induced transcriptional repression. J Cell Sci. 2016;129:3541-3552 pubmed
  16. Ajiro M, Tang S, Doorbar J, Zheng Z. Serine/Arginine-Rich Splicing Factor 3 and Heterogeneous Nuclear Ribonucleoprotein A1 Regulate Alternative RNA Splicing and Gene Expression of Human Papillomavirus 18 through Two Functionally Distinguishable cis Elements. J Virol. 2016;90:9138-52 pubmed publisher
  17. Llorian M, Gooding C, Bellora N, Hallegger M, Buckroyd A, Wang X, et al. The alternative splicing program of differentiated smooth muscle cells involves concerted non-productive splicing of post-transcriptional regulators. Nucleic Acids Res. 2016;44:8933-8950 pubmed
  18. Park W, Kim H, Kang D, Ryu J, Choi K, Lee G, et al. Comparative expression patterns and diagnostic efficacies of SR splicing factors and HNRNPA1 in gastric and colorectal cancer. BMC Cancer. 2016;16:358 pubmed publisher
  19. Miletta M, Petkovic V, Eblé A, Flück C, Mullis P. Rescue of Isolated GH Deficiency Type II (IGHD II) via Pharmacologic Modulation of GH-1 Splicing. Endocrinology. 2016;157:3972-3982 pubmed
  20. Klymenko T, Hernández López H, MacDonald A, Bodily J, Graham S. Human Papillomavirus E2 Regulates SRSF3 (SRp20) To Promote Capsid Protein Expression in Infected Differentiated Keratinocytes. J Virol. 2016;90:5047-58 pubmed publisher
  21. Ajiro M, Jia R, Yang Y, Zhu J, Zheng Z. A genome landscape of SRSF3-regulated splicing events and gene expression in human osteosarcoma U2OS cells. Nucleic Acids Res. 2016;44:1854-70 pubmed publisher
  22. Ishida K, Miyauchi K, Kimura Y, Mito M, Okada S, Suzuki T, et al. Regulation of gene expression via retrotransposon insertions and the noncoding RNA 4.5S RNAH. Genes Cells. 2015;20:887-901 pubmed publisher
  23. Rahman M, Azuma Y, Nasrin F, Takeda J, Nazim M, Bin Ahsan K, et al. SRSF1 and hnRNP H antagonistically regulate splicing of COLQ exon 16 in a congenital myasthenic syndrome. Sci Rep. 2015;5:13208 pubmed publisher
  24. Palhais B, Præstegaard V, Sabaratnam R, Doktor T, Lutz S, Burda P, et al. Splice-shifting oligonucleotide (SSO) mediated blocking of an exonic splicing enhancer (ESE) created by the prevalent c.903+469T>C MTRR mutation corrects splicing and restores enzyme activity in patient cells. Nucleic Acids Res. 2015;43:4627-39 pubmed publisher
  25. Comiskey D, Jacob A, Singh R, Tapia Santos A, Chandler D. Splicing factor SRSF1 negatively regulates alternative splicing of MDM2 under damage. Nucleic Acids Res. 2015;43:4202-18 pubmed publisher
  26. McFarlane M, MacDonald A, Stevenson A, Graham S. Human Papillomavirus 16 Oncoprotein Expression Is Controlled by the Cellular Splicing Factor SRSF2 (SC35). J Virol. 2015;89:5276-87 pubmed publisher
  27. Salton M, Voss T, Misteli T. Identification by high-throughput imaging of the histone methyltransferase EHMT2 as an epigenetic regulator of VEGFA alternative splicing. Nucleic Acids Res. 2014;42:13662-73 pubmed publisher
  28. Chang S, Chang W, Lu C, Tarn W. Alanine repeats influence protein localization in splicing speckles and paraspeckles. Nucleic Acids Res. 2014;42:13788-98 pubmed publisher
  29. Majerciak V, Lu M, Li X, Zheng Z. Attenuation of the suppressive activity of cellular splicing factor SRSF3 by Kaposi sarcoma-associated herpesvirus ORF57 protein is required for RNA splicing. RNA. 2014;20:1747-58 pubmed publisher
  30. Du C, Ma X, Meruvu S, Hugendubler L, Mueller E. The adipogenic transcriptional cofactor ZNF638 interacts with splicing regulators and influences alternative splicing. J Lipid Res. 2014;55:1886-96 pubmed publisher
  31. Jacob A, Singh R, Mohammad F, Bebee T, Chandler D. The splicing factor FUBP1 is required for the efficient splicing of oncogene MDM2 pre-mRNA. J Biol Chem. 2014;289:17350-64 pubmed publisher
  32. Rappe U, Schlechter T, Aschoff M, Hotz Wagenblatt A, Hofmann I. Nuclear ARVCF protein binds splicing factors and contributes to the regulation of alternative splicing. J Biol Chem. 2014;289:12421-34 pubmed publisher
  33. Hu Y, Ericsson I, Doseth B, Liabakk N, Krokan H, Kavli B. Activation-induced cytidine deaminase (AID) is localized to subnuclear domains enriched in splicing factors. Exp Cell Res. 2014;322:178-92 pubmed publisher
  34. Liu J, Yue Y, Han D, Wang X, Fu Y, Zhang L, et al. A METTL3-METTL14 complex mediates mammalian nuclear RNA N6-adenosine methylation. Nat Chem Biol. 2014;10:93-5 pubmed publisher
  35. Mui M, Kucharski M, Miron M, Hur W, Berghuis A, Blanchette P, et al. Identification of the adenovirus E4orf4 protein binding site on the B55? and Cdc55 regulatory subunits of PP2A: Implications for PP2A function, tumor cell killing and viral replication. PLoS Pathog. 2013;9:e1003742 pubmed publisher
  36. Li X, Johansson C, Cardoso Palacios C, Mossberg A, Dhanjal S, Bergvall M, et al. Eight nucleotide substitutions inhibit splicing to HPV-16 3'-splice site SA3358 and reduce the efficiency by which HPV-16 increases the life span of primary human keratinocytes. PLoS ONE. 2013;8:e72776 pubmed publisher
  37. Bruun G, Doktor T, Andresen B. A synonymous polymorphic variation in ACADM exon 11 affects splicing efficiency and may affect fatty acid oxidation. Mol Genet Metab. 2013;110:122-8 pubmed publisher
  38. Vivarelli S, Lenzken S, Ruepp M, Ranzini F, Maffioletti A, Alvarez R, et al. Paraquat modulates alternative pre-mRNA splicing by modifying the intracellular distribution of SRPK2. PLoS ONE. 2013;8:e61980 pubmed publisher
  39. Gu B, Eick D, Bensaude O. CTD serine-2 plays a critical role in splicing and termination factor recruitment to RNA polymerase II in vivo. Nucleic Acids Res. 2013;41:1591-603 pubmed publisher
  40. Gout S, Brambilla E, Boudria A, Drissi R, Lantuejoul S, Gazzeri S, et al. Abnormal expression of the pre-mRNA splicing regulators SRSF1, SRSF2, SRPK1 and SRPK2 in non small cell lung carcinoma. PLoS ONE. 2012;7:e46539 pubmed publisher
  41. Becker K, Braune M, Benderska N, Buratti E, Baralle F, Villmann C, et al. A retroelement modifies pre-mRNA splicing: the murine Glrb(spa) allele is a splicing signal polymorphism amplified by long interspersed nuclear element insertion. J Biol Chem. 2012;287:31185-94 pubmed publisher
  42. Nakagawa S, Ip J, Shioi G, Tripathi V, Zong X, Hirose T, et al. Malat1 is not an essential component of nuclear speckles in mice. RNA. 2012;18:1487-99 pubmed publisher
  43. Pradeepa M, Sutherland H, Ule J, Grimes G, Bickmore W. Psip1/Ledgf p52 binds methylated histone H3K36 and splicing factors and contributes to the regulation of alternative splicing. PLoS Genet. 2012;8:e1002717 pubmed publisher
  44. Markus M, Marques F, Morris B. Resveratrol, by modulating RNA processing factor levels, can influence the alternative splicing of pre-mRNAs. PLoS ONE. 2011;6:e28926 pubmed publisher
  45. Waks Z, Klein A, Silver P. Cell-to-cell variability of alternative RNA splicing. Mol Syst Biol. 2011;7:506 pubmed publisher
  46. Piekielko Witkowska A, Wiszomirska H, Wojcicka A, Poplawski P, Boguslawska J, Tanski Z, et al. Disturbed expression of splicing factors in renal cancer affects alternative splicing of apoptosis regulators, oncogenes, and tumor suppressors. PLoS ONE. 2010;5:e13690 pubmed publisher
  47. He M, Shah D, Choung H, Coffman F. The splicing factor SF2/ASF binds to ARS homologs in a human rDNA replication origin. Cell Cycle. 2009;8:2631-42 pubmed
  48. Hepperger C, Mannes A, Merz J, Peters J, Dietzel S. Three-dimensional positioning of genes in mouse cell nuclei. Chromosoma. 2008;117:535-51 pubmed publisher
  49. Inoue A, Tsugawa K, Tokunaga K, Takahashi K, Uni S, Kimura M, et al. S1-1 nuclear domains: characterization and dynamics as a function of transcriptional activity. Biol Cell. 2008;100:523-35 pubmed publisher
  50. Adair R, Liebisch G, Su Y, COLBERG POLEY A. Alteration of cellular RNA splicing and polyadenylation machineries during productive human cytomegalovirus infection. J Gen Virol. 2004;85:3541-53 pubmed